Updates and news related to prostate cancer:
Unmet Needs in Oligometastatic Prostate Cancer
Ongoing challenges for the treatment of patients with oligometastatic disease
Study Backs Broader Use of Genetic Testing in Prostate Cancer
Approximately half of prostate cancer patients with clinically actionable gene variants do not meet the NCCN guideline criteria for genetic testing, according to findings from the PROCLAIM trial.
Non-Contrast MRI May Enhance Early Detection of Prostate Cancer
Use of non-contrast MRI also showed the potential to decrease identification of clinically insignificant disease.
Biomarkers May Help Identify Black Men at Risk of Advanced Prostate Cancer
Data showed a significant association between the biomarkers and prostate cancer in Black men, but the association was not found to be significant among White men.
Very High Risk Prostate Cancer Survival Tied to Radiation Facility Volume
High-volume radiation treatment facilities contribute to better survival outcomes in men with very high-risk prostate cancer compared with low-volume centers, a new study suggests.
Study explores value of whole-body low-dose CT in prostate cancer management
This modality may obviate performing multiple imaging sessions and high-cost scans in patients diagnosed with the high-burden disease.
Free PSA Shows Utility for Helping Detect Clinically Significant and Fatal Prostate Cancer
Findings may help clinicians and patients take the next step in care of traditionally elevated PSA level.
Exercise Interventions to Improve Sexual Dysfunction
Partaking in resistance and aerobic exercise was found to improve erectile function and intercourse satisfaction among men receiving treatment for prostate cancer.
PSMA PET Improves Accuracy of Predicting Recurrence
A molecular imaging tool helps improve the accuracy of predicting the risk of cancer recurrence in patients with intermediate to high-risk prostate cancer who undergo surgery.
Emerging PET Radiotracer May Offer Multiple Advantages in Detecting Prostate Cancer
The PET radiotracer 18F-PSMA-1007 facilitated detection of at least one suspicious lesion for metastasis in nearly half of a cohort of 160 patients with prostate cancer, according to a recent study.